An ultra-sensitive ctDNA platform that fits how you actually work.
Detect signal at parts-per-million in samples your current platform calls negative. Run it as a service from our EU-accredited lab, or bring SiMSen-Seq in-house on your own instruments. Same chemistry, same sensitivity, your decision on delivery.
✓ ISO 15189 compliant · Open pipeline, raw data access · EU-based
Five things you cannot buy off the shelf elsewhere.
these are the platform-level promises. On each Solutions page they are retold in the language of pharma teams, research laboratories, or oncology clinics. Here, in plain platform terms:
Sensitivity
You detect signal at parts-per-million, in samples your current platform may call negative.
Flexibility
You choose: send samples to our accredited lab, or run SiMSen-Seq on your own instruments.
Clinical insight
You see actionable variants and tumour evolution, not just a binary positive or negative.
Transparency
You get full raw data access and an open pipeline. Bring your own bioinformatics in.
Partnership
Read the platform in whichever order serves you.
Each of the four pages below is written for a different visitor. Start where you are. Each takes about three minutes to read.
The five reasons people choose us.
If you are deciding whether to talk to us at all.
The five benefit-framed pillars that run through everything: sensitivity, flexibility, clinical insight, transparency, partnership. The shortest route to whether we are worth a conversation.
The science under the hood
If you already understand ctDNA and want the detail.
Barcoded duplex sequencing, error suppression, validated sensitivity down to single molecules. Performance data, the sample-to-result workflow, and the limitations we are open about.
SNV, SV or tumour-naive. What changes for your samples.
If you are choosing between approaches and want an honest read.
The three families of tumour-informed ctDNA monitoring, side by side, with the trade-offs each one carries. Includes a four-question decision guide for when you want a recommendation, not a comparison.
Full-service lab, or LabSuite in your own laboratory.
If the science fits and the question is how to operate it.
Two delivery models, the same chemistry. Send samples to our accredited EU lab, or run SiMSen-Seq on your own instruments with LabSuite. The trade-offs on cost, control, turnaround and capability laid out plainly.
The performance, with the receipts.
Parts-per-million sensitivity, lead time over imaging, and surveillance scans avoided in real monitoring. Every number, with its published source, lives on the evidence hub.
Speak to our scientific team
A real human, in CET/CEST time zone, who has run samples like yours..